Abstract:Protein tyrosine kinases (PTKs) function as key molecules in the signaling pathways in addition to their impact as a therapeutic target for the treatment of many human diseases, including cancer. PTKs are characterized by their ability to phosphorylate serine, threonine, or tyrosine residues and can thereby rapidly and reversibly alter the function of their protein substrates in the form of significant changes in protein confirmation and affinity for their interaction with protein partners to drive cellular functions under normal and pathological conditions. PTKs are classified into two groups: one of which represents tyrosine kinases, while the other one includes the members of the serine/threonine kinases. The group of tyrosine kinases is subdivided into subgroups: one of them includes the member of receptor tyrosine kinases (RTKs), while the other subgroup includes the member of non-receptor tyrosine kinases (NRTKs). Both these kinase groups function as an "on" or "off" switch in many cellular functions. NRTKs are enzymes which are overexpressed and activated in many cancer types and regulate variable cellular functions in response to extracellular signaling-dependent mechanisms. NRTK-mediated different cellular functions are regulated by kinase-dependent and kinase-independent mechanisms either in the cytoplasm or in the nucleus. Thus, targeting NRTKs is of great interest to improve the treatment strategy of different tumor types. This review deals with the structure and mechanistic role of NRTKs in tumor progression and resistance and their importance as therapeutic targets in tumor therapy.

Research Progress of Receptor Tyrosine Protein Kinase

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Receptor tyrosine kinases in breast cancer treatment: unraveling the potential

Research Progress of Raf-1 Protein Kinase in Signal Transduction.

Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis—New insight and futuristic vision

Research Progress of Imaging Receptor Tyrosine Kinase Targeted Drugs by Radionuclide

Advances in studies of tyrosine kinase inhibitors and their acquired resistance

Progress of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitors in the Cancer Therapy

Two key signal transduction pathways of growth factors and cytokines

Probing phosphorylation events in biological membranes: The transducer function

Research progress on anti-tumor mechanism of TAOK kinases

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

Structural Insight into Recognition of Plant Peptide Hormones by Plant Receptor Kinases

Progress in researches of the receptor tyrosine kinase EphA1

Current Status of Research and Development of New Tyrosine Kinase Inhibitors

Advances in the Research of Small Molecule Tyrosine Kinase Inhibitors

A review of study in protein kinase

Wnt Signal Transduction Pathway and Protein Kinase CK2

Imaging Strategies for Receptor Tyrosine Kinase Dimers in Living Cells

Advances in Research of Ser/Thr Kinase Polo-Like Kinase 1